SCHEMBL1066716

SCHEMBL1066716

COC(=O)c1ccc(CNc2nc3ccc(O)cc3s2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.55
PIK3CA P42336 1/20 0.55
PIK3CB P42338 1/20 0.55
PIK3CG P48736 1/20 0.55
PI4KB Q9UBF8 1/20 0.55
HSD17B10 Q99714 2/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
DYRK1A Q13627 2/20 0.53
HDAC1 Q13547 1/20 0.53
CYP3A4 P08684 1/20 0.53
KCNH2 Q12809 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
HTT P42858 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
TNF P01375 1/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064848 0.87 HDAC1 (0.68) CA1CA2DYRK1AHDAC1CYP3A4
SCHEMBL8292762 0.87 HSD17B10 (0.67) HSD17B10DYRK1AHDAC1HSD17B1DYRK1B
SCHEMBL4971075 0.84 NPC1 (0.63) CYP2C9CA1CA2HDAC1CYP3A4
SCHEMBL16554101 0.82 HTT (0.71) PIK3CAPIK3CBPIK3CGPI4KBDYRK1A
SCHEMBL3561975 0.81 DYRK1A (0.54) CYP2C9PIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL1067291 0.80 AURKB (0.70) CYP2C9HDAC1CYP3A4KCNH2LMNA
SCHEMBL210213 0.77 HDAC1 (0.81) DYRK1AHDAC1DYRK1B
SCHEMBL211650 0.77 HDAC1 (0.60) DYRK1AHDAC1HSD17B1DYRK1B
SCHEMBL8403934 0.77 HSD17B1 (0.65) CYP2C9PIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL1065095 0.75 AURKB (0.79) HDAC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868205-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7868205-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7868205-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-20080132459-A1 Inhibitors of Histone Deacetylase METHYLGENE, INC. (CA) 2008-06-05 US disclosed
US-20080132459-A1 Inhibitors of Histone Deacetylase METHYLGENE, INC. (CA) 2008-06-05 US disclosed
US-20080132459-A1 Inhibitors of Histone Deacetylase METHYLGENE, INC. (CA) 2008-06-05 US disclosed
EP-1663953-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2006-06-07 EP disclosed
WO-2005030705-A9 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2006-04-20 WO disclosed
WO-2005030705-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2005-04-07 WO disclosed
WO-2005030704-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132459-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 CYP2C9 4774/4885PIK3CA 2549/4885PIK3CB 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.